Classification
- Anatomical main groupMMusculo-skeletal system
- Therapeutic subgroupM05
- Pharmacological subgroupM05B
- Chemical subgroupM05BX
- Chemical substanceM05BX04Denosumab
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Netherlands
CBG-MEB · 35 registrations
- Acvybra 60 mg oplossing voor injectie in een voorgevulde spuitOplossing voor injectie · Reddy Holding GmbH
- Bildyos 60 mg oplossing voor injectieOplossing voor injectie · Sciencepharma Sp. z o.o.
- Bildyos 60 mg oplossing voor injectie in een voorgevulde spuitOplossing voor injectie · Sciencepharma Sp. z o.o.
- Bilprevda 120 mg oplossing voor injectieOplossing voor injectie · Sciencepharma Sp. z o.o.
European Union
EMA · 31 registrations
At a glance
- ATC code
- M05BX04
- ATC group
- Musculo-skeletal system
- Registers
- 12
- Historical lists
- 3
- Registrations
- 220
- With their own page
- 210
- Companies
- 63
All medicines with Denosumab
Human medicines from every register that match Denosumab by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
220 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Denosumab-DSSB | United States | 60MG/ML, 70MG/ML | injectable | Marketed | Samsung Bioepis Co LTD |
| Denosumab Intas | Croatia | Authorised | |||
| Denosumab Ascend 120 mg oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Ascend GmbH | |
| Denosumab Intas 60 mg oplossing voor injectie in een voorgevulde spuit | Netherlands | Oplossing voor injectie | Authorised | Intas Third Party Sales 2005, S.L. | |
| Vysribli (previously Denosumab Intas) | European Union | Authorised | Intas Third Party Sales 2005 S.L. | ||
| Enoby | United States | 60MG/ML | solution | Marketed | Hikma Pharmaceuticals USA INC |
| Degevma | United States | 120MG/1.7ML | Injection | Marketed | Teva Pharmaceuticals, Inc. |
| Aukelso | United States | 120MG/1.7ML | injectable | Marketed | Biocon Biologics INC |
| Bomyntra | United States | 120MG/1.7ML | injection | Marketed | Fresenius Kabi USA LLC |
| Boncresa | United States | 60MG/ML | injectable | Marketed | Amneal Pharms LLC |
| Bosaya | United States | 60MG/ML | injectable | Marketed | Biocon Biologics INC |
| Conexxence | United States | 60MG/ML | injection | Marketed | Fresenius Kabi USA LLC |
| Jubbonti | United States | 60MG/ML | injectable | Marketed | Sandoz INC |
| Osenvelt | United States | 120MG/1.7ML | injectable | Marketed | Celltrion INC |
| Prolia | United States | 60MG/ML | injectable | Marketed | Amgen |
| Stoboclo | United States | 60MG/ML | injectable | Marketed | Celltrion INC |
| Wyost | United States | 120MG/1.7ML | injectable | Marketed | Sandoz INC |
| Xgeva | United States | 70MG/ML | injectable | Marketed | Amgen |
| Xtrenbo | United States | 120MG/1.7ML | solution | Marketed | Hikma Pharmaceuticals USA INC |
| Bildyos | United States | 60MG/ML | injectable | Marketed | Shanghai Henlius Biotech |
| Bilprevda | United States | 120MG/1.7ML | injectable | Marketed | Shanghai Henlius Biotech |
| Bilprevda | United States | 120MG/1.7ML | Injection | Marketed | Shanghai Henlius Biotech, Inc. |
| Bomyntra | United States | 120MG/1.7ML | Injection | Marketed | Fresenius Kabi USA, LLC |
| Jubereq | United States | 120MG/1.7ML | injectable | Marketed | Accord Biopharma INC. |
| Ospomyv | United States | 60MG/ML | injectable | Marketed | Samsung Bioepis Co LTD |